Skip to search formSkip to main contentSkip to account menu

NIK-333

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA Aims: Hepatocellular carcinoma (HCC) is the… 
2012
2012
Development of an effective low-cost anti-acquired immunodeficiency syndrome (AIDS) drugs is needed for treatment of AIDS… 
2011
2011
Aim:  NIK‐333 (an acyclic retinoid) has been reported to prevent recurrence of hepatocellular carcinoma (HCC) in patients after… 
2006
2006
Adult T-cell leukemia (ATL) is caused by human T-cell leukemia virus type I (HTLV-I) and remains incurable. NIK-333, a novel… 
2005
2005
Abstract: We investigated the preventive effects of a synthetic acyclic retinoid, NIK-333, on the early and late events of… 
2004
2004
The present study was designed to determine the effects of NIK-333, a synthetic acyclic retinoid, on N-diethylnitrosamine (DEN…